The Real 4-1-1Tirzepatide vs. Semaglutide: The Truth About These Weight Loss Drugs No One’s Telling You
This episode unpacks the latest head-to-head research on tirzepatide and semaglutide, exploring their metabolic effects, weight loss outcomes, and real-world challenges in access and safety. Dr. Chelsea McGee and guests discuss groundbreaking trial data, the science behind these obesity drugs, and the human stories caught in the crossfire of drug shortages and regulatory changes.
About the podcast
I am Dr. Chelsea McGee AND Welcome to The Real 411—where we make it our mission to dive deeper, think bigger, and challenge the narrative. Every day, we are flooded with headlines. These headlines are quick, catchy, and often misleading. News is everywhere, but how much of it is the complete truth? How often do we stop and ask, "What's really going on?" Because here’s the thing—the story is never just the headline.